Affimed to Present at the Jefferies Global Healthcare Conference
May 30 2018 - 4:00AM
Heidelberg, Germany, May 30, 2018 - Affimed N.V.
(Nasdaq: AFMD), a clinical stage biopharmaceutical company focused
on discovering and developing highly targeted cancer
immunotherapies, announced today that Dr. Adi Hoess, CEO, will
present at the Jefferies Global Healthcare Conference on Wednesday,
June 6, 2018 at 4:30 pm ET.
A live webcast of the conference presentation
can be accessed through the "Events" section on the "Investors
& Media" page of the Affimed website at
www.affimed.com/events.php. A replay of the presentation will be
available from Affimed's website for 30 days following the
conference.
About Affimed N.V.Affimed (Nasdaq: AFMD) engineers
targeted immunotherapies, seeking to cure patients by harnessing
the power of innate and adaptive immunity (NK and T cells). We are
developing single and combination therapies to treat cancers and
other life-threatening diseases. For more information, please visit
www.affimed.com.
Contact:Anca Alexandru, Head of Communications, EU
IRPhone: +49 6221 64793341E-Mail: a.alexandru@affimed.com,
IR@affimed.com
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Apr 2024 to May 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Affimed NV (NASDAQ): 0 recent articles
More News Articles